Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Genpact Limited's financial performance in the second quarter of 2025 presented a mix of strengths and potential challenges for investors to consider.</li><li>The company reported a revenue of $1.25 billion, marking a 7% year-over-year increase, showing robust growth across its business segments.</li><li>Profitability also improved, with gross margin expanding by 50 basis points and adjusted operating income margin increasing by 40 basis points over the previous year.</li></ul>

Genpact Limited's financial performance in the second quarter of 2025 presented a mix of strengths and potential challenges for investors to consider.The company reported a revenue of $1.25 billion, marking a 7% year-over-year increase, showing robust growth across its business segments.Profitability also improved, with gross margin expanding by 50 basis points and adjusted operating income margin increasing by 40 basis points over the previous year.

Genpact’s AI Gigafactory Is Live—Could 270+ Solutions Rebuild Its Growth Story?

<ul><li>Genpact Limited reported its financial results for the first quarter of 2025, showcasing both positive growth and challenges.</li><li>The company achieved total revenue of $1.215 billion, reflecting an 8.3% year-over-year increase in constant currency, surpassing the upper range of their guidance.</li><li>Gross margin and adjusted operating income margin also exceeded expectations, partly driven by more substantial revenue performance.</li></ul>

Genpact Limited reported its financial results for the first quarter of 2025, showcasing both positive growth and challenges.The company achieved total revenue of $1.215 billion, reflecting an 8.3% year-over-year increase in constant currency, surpassing the upper range of their guidance.Gross margin and adjusted operating income margin also exceeded expectations, partly driven by more substantial revenue performance.

Genpact Limited: AI Gigafactory Development As a Significant Growth Avenue!

<ul><li>Genpact Limited reported a strong performance in the fourth quarter of 2024, with revenue reaching $1.25 billion, reflecting a 9% year-over-year increase.</li><li>The company showcased a particularly impressive growth in their Data-Tech-AI segment, which rose by 12% year-over-year, showcasing the potential and growth of this sector within the organization.</li><li>Additionally, Digital Operations saw a 6% year-over-year increase, indicating strong demand across their business segments.</li></ul>

Genpact Limited reported a strong performance in the fourth quarter of 2024, with revenue reaching $1.25 billion, reflecting a 9% year-over-year increase.The company showcased a particularly impressive growth in their Data-Tech-AI segment, which rose by 12% year-over-year, showcasing the potential and growth of this sector within the organization.Additionally, Digital Operations saw a 6% year-over-year increase, indicating strong demand across their business segments.

Genpact Limited: Will Its Advancement in Data, Tech, and AI Help Alter The Playing Field?

<ul><li>Genpact Limited has reported a strong financial performance for the third quarter of 2024, marked by robust revenue growth and improved profitability metrics.</li><li>Revenue for the quarter reached $1.21 billion, representing a 7% increase year-over-year, surpassing the high end of the company's guidance range.</li><li>This growth was primarily driven by the Data-Tech-AI and Digital Operations segments, with the former growing by 9% and the latter by 5%.</li></ul>

Genpact Limited has reported a strong financial performance for the third quarter of 2024, marked by robust revenue growth and improved profitability metrics.Revenue for the quarter reached $1.21 billion, representing a 7% increase year-over-year, surpassing the high end of the company's guidance range.This growth was primarily driven by the Data-Tech-AI and Digital Operations segments, with the former growing by 9% and the latter by 5%.

Genpact Limited: An Insight Into Its Data-Tech-AI Solutions & Other Major Drivers

APAC IPOs & Placements, Aequitas Research

Akshat Shah

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sagility-india" target="_blank" data-smartkarma-citation="entities:43717:1" rel="noopener">Sagility India (2058883D IN)</a> (Sagility) raised around US$250m in its India IPO in Nov 2024. The lockup on its pre-IPO investors is set to expire soon.</li>
<li>Sagility is a pure-play healthcare focused solutions and services provider to Payers (U.S. health insurance companies), and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies).</li>
<li>In this note, we will talk about the lockup dynamics, possible placement and updates since our last note.</li>
</ul>



Sagility India (2058883D IN) (Sagility) raised around US$250m in its India IPO in Nov 2024. The lockup on its pre-IPO investors is set to expire soon.
Sagility is a pure-play healthcare focused solutions and services provider to Payers (U.S. health insurance companies), and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies).
In this note, we will talk about the lockup dynamics, possible placement and updates since our last note.


Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

United States

Genpact Limited designs and manages business operations to manage risk and compliance. The Company focuses on the areas of finance and procurement, financial services account servicing, claims management, regulatory affairs, and industrial asset optimization. Genpact operates worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genpact Ltd (G US)

Genpact’s AI Gigafactory Is Live—Could 270+ Solutions Rebuild Its Growth Story?

Genpact Limited's financial performance in the second quarter of 2025 presented a mix of strengths and potential challenges for investors to...

Baptista Research

Genpact Limited: AI Gigafactory Development As a Significant Growth Avenue!

Genpact Limited reported its financial results for the first quarter of 2025, showcasing both positive growth and challenges. The company achieved...

Baptista Research

Genpact Limited: Will Its Advancement in Data, Tech, and AI Help Alter The Playing Field?

Genpact Limited reported a strong performance in the fourth quarter of 2024, with revenue reaching $1.25 billion, reflecting a 9% year-over-year...

Baptista Research

Genpact Limited: An Insight Into Its Data-Tech-AI Solutions & Other Major Drivers

Genpact Limited has reported a strong financial performance for the third quarter of 2024, marked by robust revenue growth and improved...

Baptista Research

Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

Sagility B.V. plans to offload up to 15.02% stake in Sagility India via block deals worth INR26.7bn (US$314.7m). The secondary share sale is priced...

Akshat Shah

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)